Clin2
NCT06867419Possibly a fitRecruiting

Metabolic effects on fatty liver disease score

Metabolic Dysfunction-Associated Steatotic Liver Disease

Part of Digestive system, Hormones & metabolism clinical trials.

This study looks at how certain features of your metabolism affect a simple score (called the FAST score) in people with fatty liver disease (MASLD). It aims to help doctors better understand and manage the condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
385 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have been diagnosed with fatty liver disease (MASLD) using a special scan (VCTE-CAP), which measures fat and stiffness in your liver.
  • You do not drink more than 2 alcoholic drinks a day (for men) or more than 1 drink a day (for women).
  • You have never tested positive for hepatitis B or C.
  • You do not have autoimmune hepatitis or other metabolic liver conditions (like Wilson’s or hemochromatosis).
  • You have no known liver tumors or nodules.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07165028Recruiting· Phase 3
Study of new drugs for fatty liver with scarring

This trial tests new medicines for adults with fatty liver disease (MASLD) that has already caused some liver scarring. It aims to see if these drugs can help prevent the liver disease from getting worse.

Tuscaloosa, Alabama
NCT07082751Not yet recruiting
Predicting the course of fatty liver cirrhosis

This study aims to build a tool to predict how MASLD-related cirrhosis (fatty liver disease leading to liver scarring) will progress. It may help doctors and patients better understand the outlook and plan care.

Beijing, Beijing Municipality
NCT06920316Not yet recruiting· Phase 4
Digital diet and exercise program for fatty liver disease

This trial tests a digital diet and exercise program to help reduce liver scarring in people with fatty liver disease. You'll use an app or online tool to follow healthy eating and activity routines, which may slow or reverse liver damage.

London, London
NCT06703450Enrolling by invitation
Liver fibrosis study with MRI for MASLD patients

This study is testing whether an MRI can help doctors see liver scarring (fibrosis) in people with MASLD, a type of fatty liver disease. It is for patients who already need a liver biopsy as part of their care, to compare the MRI results with the biopsy.

New York, New York
NCT07159386Recruiting
Detecting advanced liver scarring in fatty liver disease

This study tests a new screening tool to find advanced liver scarring in people with liver disease linked to diabetes. It helps doctors decide who needs more tests or specialist care.

Charleston, South Carolina
NCT06506513Recruiting
Can exercise help fatty liver disease?

This study tests whether a program of physical activity can reduce fat in the muscles and liver of people with MASLD, a type of fatty liver disease linked to metabolism. It looks at how exercise might help improve liver health.

Brussels

Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.